XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 8 - Stock-based Compensation Expense (Tables)
6 Months Ended
Jun. 30, 2022
Notes Tables  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three months ended June 30,

  

Six months ended June 30,

 
  

2022

  

2021

  

2022

  

2021

 
                 

Cost of revenue

 $8,440  $-  $16,880  $- 

Research and development

  13,417   -   26,316   - 

Selling and shipping

  5,398   -   10,796   - 

General and administrative

  64,466   62,078   134,839   112,451 
                 

Total

 $91,721  $62,078  $188,831  $112,451 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

2007 Share Incentive Plan

                        
  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Number of shares

  220,000   -   -   (25,000)  195,000   195,000 

Weighted average exercise price per share

 $12.56   -   -  $15.00  $12.24  $12.24 

2016 Share Incentive Plan

                        
  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Number of shares

  398,500   12,500   -   (6,500)  404,500   102,500 

Weighted average exercise price per share

 $4.43  $4.60   -  $4.01  $4.44  $5.33 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Stock Price

 $4.60 

Exercise Price

 $4.60 

Dividend yield

  0%

Expected volatility

  68%

Risk-Free interest rate

  1.79%

Expected life (in years)

  6.00 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
      

Options Outstanding

  

Options Exercisable

 
          

Weighted

  

Weighted

          

Weighted

     
          

Average

  

Average

          

Average

     

Exercise

  

Number

  

Remaining

  

Exercise

  

Intrinsic

  

Number

  

Exercise

  

Intrinsic

 

Price Range

  

Outstanding

  

Contractual

  

Price

  

Value

  

Exercisable

  

Price

  

Value

 
 $4.00-7.00   384,500   8.8  $4.25  $0   82,500  $4.66  $0 
 $7.01-10.00   20,000   5.8  $8.07  $0   20,000  $8.07  $0 
 $10.01-12.00   120,000   4.7  $10.52  $0   120,000  $10.52  $0 
 $12.01-15.00   75,000   .2  $15.00  $0   75,000  $15.00  $0 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
      

Weighted

 
  

Shares of

  

Average Grant

 
  

Restricted

  

Date Fair

 
  

Stock Units

  

Value

 

Unvested outstanding at December 31, 2021

  5,500  $4.82 

Granted

  -  $- 

Vested

  (5,500) $4.82 

Forfeited/Cancelled

  -  $- - 
         

Unvested outstanding at June 30, 2022

  -  $-